Search

Trigonella foenum-graecum L. (fenugreek) has been described earlier and its use in ancient medicinal practice is well known. The hypoglycemic effects of fenugreek have been studied in many animal models and diabetic patients. The purpose of this study was to examine the preventive efficiency of dietary fenugreek on diet-induced metabolic diseases in rats. The diets used in this study were a standard diet, a high-fat high-sucrose (HFS) diet, and a HFS diet containing 0.5 g/kg b. w./day fenugreek based on the modified version of the AIN-93G purified diet, for 12 weeks, respectively. The rats fed the HFS diet containing fenugreek showed significantly lower fasting insulin levels and HOMA-IR than the rats fed the HFS diet. Therefore, fenugreek improved insulin sensitivity in rats. The triglyceride and total cholesterol levels in the plasma were significantly lower in the fenugreek-administered group. Moreover, distinct reductions of triglyceride, total cholesterol, free fatty acid, and phospholipid levels in the liver were found in the rats fed the HFS diet containing fenugreek. These results suggest that fenugreek enhanced insulin sensitivity at least partly by improving lipid metabolism disorders in the plasma and the liver in the rats induced by the HFS diet.

The objectives of this study were to evaluate the hypoglycemic effects and histological changes of pancreatic islets after receiving Morus alba leave extract in normal and diabetic rats. Diabetes was induced by injection of streptozotocin (STZ, 45 mg/kg) intraperitoneally. All diabetic rats were divided into 5 groups, each of which was orally received one of the following; vehicle, glibenclamide and leave extract (150, 300 and 600 mg/kg) for 12 days. The results showed that the leave extract at the doses of 300 and 600 mg/kg significantly (p

A water extract of the Oriental crude drug “shikon”, LITHOSPERMUM ERYTHRORHIZON roots, remarkably diminished the plasma sugar level in mice. Fractionation of the extract by monitoring the activity yielded three glycans, lithospermans A, B and C. These glycans exerted marked hypoglycemic effects in normal and alloxan-induced hyperglycemic mice.

An aqueous methanol/water extract of the Oriental crude drug “bushi”, ACONITUM CARMICHAELI roots from Japan, markedly reduced the blood sugar level in mice. Activity-guided fractionation of the extract furnished four glycans, aconitans A, B, C and D. These glycans exhibited prominent hypoglycemic effects in normal and alloxan-produced hyperglycemic mice.

Administration of an aqueous methanol/water extract of the Oriental crude drug “maō” (Ephedra), EPHEDRA DISTACHYA herbs, caused transient hyperglycemia followed by long lasting hypoglycemia in mice. Activity-guided fractionation of the extract led to isolation of five glycans, ephedrans A, B, C, D and E, which exhibited significant hypoglycemic effects in normal and alloxan-induced hyperglycemic mice.

A water extract of the Oriental crude drug “yokui-nin” (coix seeds), COIX LACHRYMA-JOBI var, MA-YUEN seeds, disclosed a marked hypoglycemic action when administered to mice. Fractionation of the extract, by monitoring the pharmacological activity, led to isolation of three glycans, coixans A, B and C. These components elicited remarkable hypoglycemic effects in normal and hyperglycemic mice treated with alloxan.

Evaluation of hypoglycemic and antitumor effects of some heteroglycans from Ganoderma lucidum fruiting bodies. In mice, most of the heteroglycans exhibited hypoglycemic effects whose potencies, however, were rather weak as compared with those of ganoderans. Further, the potencies of these hypoglycemic effects were found to be not in parallel with those of the antitumor effects against sarcoma 180 in mice